Considerations for Novel Pharmacologic Agents in Eating Disorder Treatment

Join us for the last of our virtual trainings! Where the folks from Within inform us about something we're all seeing our clients struggle with. Anti-fat attitudes and misconceptions about weight as an indicator of health have fueled the weight loss industry for decades. Various pharmaceutical approaches aiming to address weight-related concerns have been introduced on the market, only to be withdrawn due to limited efficacy and/or concerning adverse effects. The recent emergence of glucagon-like peptide 1 (GLP-1) and gastric inhibitory
polypeptide (GIP) receptor agonists (RAs) has reignited the promise of a panacea for “poor health” and body dissatisfaction, albeit at a cost. During this presentation the historic use of pharmacologic agents use for weight loss will be briefly reviewed. The biopsychosocial implications of GLP-1 and GIP RAs will be discussed, and considerations for practitioners working with individuals experiencing weight stigma, fatphobia, disordered eating and eating disorders will be highlighted. Session attendees will walk away with a full picture of how and why clients might pursue the use of GLP-1 and GIP RAs, the known and unknown implications for such choices, and how to best counsel clients and inform non-eating disorder professionals about these weight loss pharmacological agents.

Learning Objectives:
● Identify the GLP-1 receptor agonists, describe their main mechanisms of
action, and state their primary indications and secondary weight-related
indications
● Explain the the biopsychosocial implications of these medications, including
established and unknown effects
● Discuss specific considerations relevant to these medications when working
with clients with eating disorders

Within Health provides comprehensive, personalized and remote treatment for those suffering from eating disorders. Built on a tech-enabled and digitally native platform, Within brings full multidisciplinary teams, remote patient monitoring, food delivery and aftercare - all into the home - to increase access, improve outcomes and promote healing for tens of millions of Americans. 

We offer virtual partial hospitalization programs (PHP+) and intensive outpatient (IOP+) levels of care, depending on each individual client’s needs and progress. All scheduling is flexible and determined on an individual basis. Treating ages 13+ and all genders. 

1.5 CEs are provided for this experience. 

CE’s are provided by The International Association of Eating Disorders Professionals, PO Box 1295, Pekin, IL 61555.  sarah@iaedpfoundation.com

The International Association of Eating Disorders Professionals has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5912.  Programs that do not qualify for NBCC credit are clearly identified The International Association of Eating Disorders Professionals is solely responsible for all aspects of the program.